These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 39222284)

  • 1. The contribution of white matter changes to clinical phenotype in progressive supranuclear palsy.
    Tepedino MF; Diana F; Abate F; Avallone AR; Caterino M; Erro R; Pellecchia MT; Manara R; Barone P; Picillo M
    J Neurol; 2024 Oct; 271(10):6866-6875. PubMed ID: 39222284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Track density imaging: A reliable method to assess white matter changes in Progressive Supranuclear Palsy with predominant parkinsonism.
    Nigro S; Barbagallo G; Bianco MG; Morelli M; Arabia G; Quattrone A; Gasparini S; Cascini GL; Quattrone A
    Parkinsonism Relat Disord; 2019 Dec; 69():23-29. PubMed ID: 31665684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Automatic Morphology-Based Classification of Parkinson's Disease and Progressive Supranuclear Palsy.
    Talai AS; Ismail Z; Sedlacik J; Boelmans K; Forkert ND
    Clin Neuroradiol; 2019 Dec; 29(4):605-614. PubMed ID: 30218110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of vascular risk factors and white matter hyperintensities on the degree of motor impairment in Parkinson's disease].
    Derejko M; Sławek J; Wieczorek D; Dubaniewicz M; Lass P
    Neurol Neurochir Pol; 2006; 40(4):276-83. PubMed ID: 16967348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease.
    Burciu RG; Ofori E; Shukla P; Planetta PJ; Snyder AF; Li H; Hass CJ; Okun MS; McFarland NR; Vaillancourt DE
    Mov Disord; 2015 Aug; 30(9):1248-58. PubMed ID: 26148135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Track density imaging in progressive supranuclear palsy: A pilot study.
    Nigro S; Bianco MG; Arabia G; Morelli M; Nisticò R; Novellino F; Salsone M; Augimeri A; Quattrone A
    Hum Brain Mapp; 2019 Apr; 40(6):1729-1737. PubMed ID: 30474903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation patterns in the frontal lobe white matter of multiple system atrophy, Parkinson's disease, and progressive supranuclear palsy: a cross-comparative investigation.
    Murthy M; Fodder K; Miki Y; Rambarack N; De Pablo Fernandez E; Pihlstrøm L; Mill J; Warner TT; Lashley T; Bettencourt C
    Acta Neuropathol; 2024 Jul; 148(1):4. PubMed ID: 38995454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disrupted structural connectivity of fronto-deep gray matter pathways in progressive supranuclear palsy.
    Abos A; Segura B; Baggio HC; Campabadal A; Uribe C; Garrido A; Camara A; Muñoz E; Valldeoriola F; Marti MJ; Junque C; Compta Y
    Neuroimage Clin; 2019; 23():101899. PubMed ID: 31229940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-Brain Magnetic Resonance Spectroscopy Reveals Distinct Alterations in Neurometabolic Profile in Progressive Supranuclear Palsy.
    Klietz M; Mahmoudi N; Maudsley AA; Sheriff S; Bronzlik P; Almohammad M; Nösel P; Wegner F; Höglinger GU; Lanfermann H; Ding XQ
    Mov Disord; 2023 Aug; 38(8):1503-1514. PubMed ID: 37289057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic potential of automated tractography in progressive supranuclear palsy variants.
    Potrusil T; Krismer F; Beliveau V; Seppi K; Müller C; Troger F; Göbel G; Steiger R; Gizewski ER; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2020 Mar; 72():65-71. PubMed ID: 32113070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S; Calandra-Buonaura G; Manners DN; Testa C; Gibertoni D; Evangelisti S; Sambati L; Guarino M; De Massis P; Gramegna LL; Bianchini C; Rucci P; Cortelli P; Lodi R; Tonon C
    Neuroimage Clin; 2016; 11():736-742. PubMed ID: 27330973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive supranuclear palsy and idiopathic Parkinson's disease are associated with local reduction of in vivo brain viscoelasticity.
    Lipp A; Skowronek C; Fehlner A; Streitberger KJ; Braun J; Sack I
    Eur Radiol; 2018 Aug; 28(8):3347-3354. PubMed ID: 29460073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hyperintensities on MRI in dementia with Lewy bodies, Parkinson's disease with dementia, and Alzheimer's disease.
    Joki H; Higashiyama Y; Nakae Y; Kugimoto C; Doi H; Kimura K; Kishida H; Ueda N; Nakano T; Takahashi T; Koyano S; Takeuchi H; Tanaka F
    J Neurol Sci; 2018 Feb; 385():99-104. PubMed ID: 29406924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of MRI white matter hyperintensities on dementia in Parkinson's disease in relation to the homocysteine level and other vascular risk factors.
    Sławek J; Roszmann A; Robowski P; Dubaniewicz M; Sitek EJ; Honczarenko K; Gorzkowska A; Budrewicz S; Mak M; Gołąb-Janowska M; Koziorowska-Gawron E; Droździk M; Kurzawski M; Bandurski T; Białecka M
    Neurodegener Dis; 2013; 12(1):1-12. PubMed ID: 22831964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease.
    Price S; Paviour D; Scahill R; Stevens J; Rossor M; Lees A; Fox N
    Neuroimage; 2004 Oct; 23(2):663-9. PubMed ID: 15488416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of white matter damage in progressive supranuclear palsy with predominant parkinsonism.
    Caso F; Agosta F; Ječmenica-Lukić M; Petrović I; Meani A; Kostic VS; Filippi M
    Parkinsonism Relat Disord; 2018 Apr; 49():95-99. PubMed ID: 29336906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal neuroimaging relationships in progressive supranuclear palsy.
    Sintini I; Schwarz CG; Senjem ML; Reid RI; Botha H; Ali F; Ahlskog JE; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
    Parkinsonism Relat Disord; 2019 Sep; 66():56-61. PubMed ID: 31279635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.